Daniel Paiva Barros de Abreu

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): A One Year Period Follow Up Phase 4 Study”.

Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): A One Year Period Follow Up Phase 4 Study

Frontiers in Immunology(2022)10.3389/fimmu.2022.918896

N/A

0DataRank · unranked

21 citations

Nathalie Bonatti Franco Almeida, Priscilla Soares Filgueiras, Camila Amormino Corsini, Sarah Vieira Contin Gomes, Daniel Alvim Pena de Miranda +18 more

Uncovering the structural flexibility of SARS-CoV-2 glycoprotein spike variants

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.04.20.488873

N/A

0DataRank · unranked

0 citations

Túlio M. Lima, Renata G. F. Alvim, Fernanda B. A. Victorio, Daniel Paiva Barros de Abreu, Federico F. Marsili +9 more